Table of Contents Author Guidelines Submit a Manuscript
Malaria Research and Treatment
Volume 2015 (2015), Article ID 279028, 7 pages
http://dx.doi.org/10.1155/2015/279028
Research Article

Occurrence of pfatpase6 Single Nucleotide Polymorphisms Associated with Artemisinin Resistance among Field Isolates of Plasmodium falciparum in North-Eastern Tanzania

1Kilimanjaro Christian Medical University College and Kilimanjaro Clinical Research Institute, Moshi, Tanzania
2Sokoine University of Agriculture, Morogoro, Tanzania
3National Institute for Medical Research, Tanga, Tanzania

Received 21 October 2014; Accepted 12 December 2014

Academic Editor: Sanjeev Krishna

Copyright © 2015 Jaffu Chilongola et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. E. Martin, R. V. Marchetti, A. I. Cowan, S. M. Howitt, S. Bröer, and K. Kirk, “Chloroquine transport via the malaria parasite's chloroquine resistance transporter,” Science, vol. 325, no. 5948, pp. 1680–1682, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. C. J. M. Whitty, C. Chandler, E. Ansah, T. Leslie, and S. G. Staedke, “Deployment of ACT antimalarials for treatment of malaria: challenges and opportunities,” Malaria Journal, vol. 7, supplement 1, article S7, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. H. Noedl, Y. Se, K. Schaecher, B. L. Smith, D. Socheat, and M. M. Fukuda, “Evidence of artemisinin-resistant malaria in Western Cambodia,” The New England Journal of Medicine, vol. 359, no. 24, pp. 2619–2620, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. H. Noedl, D. Socheat, and W. Satimai, “Artemisinin-resistant malaria in Asia,” The New England Journal of Medicine, vol. 361, no. 5, pp. 540–541, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. R. A. Kavishe, P. Paulo, R. D. Kaaya et al., “Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania,” Malaria Journal, vol. 13, no. 1, p. 264, 2014. View at Publisher · View at Google Scholar · View at PubMed
  6. S. I. Matondo, G. S. Temba, A. A. Kavishe et al., “High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in Tanzania,” Malaria Journal, vol. 13, no. 1, article 152, 2014. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. U. Eckstein-Ludwig, R. J. Webb, I. D. A. Van Goethem et al., “Artemisinins target the SERCA of Plasmodium falciparum,” Nature, vol. 424, no. 6951, pp. 957–961, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. I. D. Ferreira, A. Martinelli, L. A. Rodrigues et al., “Plasmodium falciparum from Pará state (Brazil) shows satisfactory in vitro response to artemisinin derivatives and absence of the S769N mutation in the SERCA-type PfATPase6,” Tropical Medicine & International Health, vol. 13, no. 2, pp. 199–207, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. R. Jambou, E. Legrand, M. Niang et al., “Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6,” The Lancet, vol. 366, no. 9501, pp. 1960–1963, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. M. Menegon, A. R. Sannella, G. Majori, and C. Severini, “Detection of novel point mutations in the Plasmodium falciparumATPase6 candidate gene for resistance to artemisinins,” Parasitology International, vol. 57, no. 2, pp. 233–235, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. K. Mugittu, B. Genton, H. Mshinda, and H. P. Beck, “Molecular monitoring of Plasmodium falciparum resistance to artemisinin in Tanzania,” Malaria Journal, vol. 5, article 126, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. R. Jambou, A. Martinelli, J. Pinto et al., “Geographic structuring of the Plasmodium falciparum sarco (endo) plasmic reticulum Ca2+ ATPase (PfSERCA) gene diversity,” PLoS ONE, vol. 5, no. 2, Article ID e9424, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. S. Takala-Harrison, T. G. Clark, C. G. Jacob et al., “Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 1, pp. 240–245, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. A.-C. Uhlemann, A. Cameron, U. Eckstein-Ludwig et al., “A single amino acid residue can determine the sensitivity of SERCAs to artemisinins,” Nature Structural and Molecular Biology, vol. 12, no. 7, pp. 628–629, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. A. A. Djimdé, A. Dolo, A. Ouattara, S. Diakité, C. V. Plowe, and O. K. Doumbo, “Molecular diagnosis of resistance to antimalarial drugs during epidemics and in war zones,” Journal of Infectious Diseases, vol. 190, no. 4, pp. 853–855, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. M. L. Ibrahim, N. Steenkeste, N. Khim et al., “Field-based evidence of fast and global increase of Plasmodium falciparum drug-resistance by DNA-microarrays and PCR/RFLP in Niger,” Malaria Journal, vol. 8, no. 32, pp. 1–9, 2009. View at Google Scholar
  17. J. G. Kublin, F. K. Dzinjalamala, D. D. Kamwendo et al., “Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria,” Journal of Infectious Diseases, vol. 185, no. 3, pp. 380–388, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. M. K. Laufer, P. C. Thesing, N. D. Eddington et al., “Return of chloroquine antimalarial efficacy in Malawi,” The New England Journal of Medicine, vol. 355, no. 19, pp. 1959–1966, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. S. Gesase, R. D. Gosling, R. Hashim et al., “High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in Northern Tanzania and the emergence of dhps resistance mutation at codon 581,” PLoS ONE, vol. 4, no. 2, Article ID e4569, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. V. Lakshmanan, P. G. Bray, D. Verdier-Pinard et al., “A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance,” The EMBO Journal, vol. 24, no. 13, pp. 2294–2305, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. S. Zakeri, S. Hemati, S. Pirahmadi, M. Afsharpad, A. Raeisi, and N. D. Djadid, “Molecular assessment of atpase6 mutations associated with artemisinin resistance among unexposed and exposed Plasmodium falciparum clinical isolates to artemisinin-based combination therapy,” Malaria Journal, vol. 11, article 373, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. M. T. Duraisingh, C. Roper, D. Walliker, and D. C. Warhurst, “Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum,” Molecular Microbiology, vol. 36, no. 4, pp. 955–961, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. M. T. Duraisingh and A. F. Cowman, “Contribution of the pfmdr1 gene to antimalarial drug-resistance,” Acta Tropica, vol. 94, no. 3, pp. 181–190, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. R. N. Price, A.-C. Uhlemann, M. van Vugt et al., “Molecular and pharmacological determinants of the therapeutic response to artemether-lumefentrine in multidrug-resistant Plasmodium falciparum malaria,” Clinical Infectious Diseases, vol. 42, no. 11, pp. 1570–1577, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. M. B. Reed, K. J. Sallba, S. R. Caruana, K. Kirk, and A. F. Cowman, “Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum,” Nature, vol. 403, no. 6772, pp. 906–909, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. P. Rohrbach, C. P. Sanchez, K. Hayton et al., “Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparum,” The EMBO Journal, vol. 25, no. 13, pp. 3000–3011, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. A. B. S. Sidhu, S. G. Valderramos, and D. A. Fidock, “pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum,” Molecular Microbiology, vol. 57, no. 4, pp. 913–926, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. S. R. Meshnick, “Artemisinin: mechanisms of action, resistance and toxicity,” International Journal for Parasitology, vol. 32, no. 13, pp. 1655–1660, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Cui, Z. Wang, H. Jiang, D. Parker, H. Wang, and X.-Z. Su, “Lack of association of the S769N mutation in Plasmodium falciparum SERCA (PfATP6) with resistance to artemisinins,” Antimicrobial Agents and Chemotherapy, vol. 56, no. 5, pp. 2546–2552, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. D. A. Fidock, R. T. Eastman, S. A. Ward, and S. R. Meshnick, “Recent highlights in antimalarial drug resistance and chemotherapy research,” Trends in Parasitology, vol. 24, no. 12, pp. 537–544, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. S. Dahlström, M. I. Veiga, P. Ferreira et al., “Diversity of the sarco/endoplasmic reticulum Ca2+-ATPase orthologue of Plasmodium falciparum (PfATP6),” Infection, Genetics and Evolution, vol. 8, no. 3, pp. 340–345, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. R. Tahar, P. Ringwald, and L. K. Basco, “Molecular epidemiology of malaria in Cameroon. XXVIII. In vitro activity of dihydroartemisinin against clinical isolates of Plasmodium falciparum and sequence analysis of the P. falciparum ATPase 6 gene,” The American Journal of Tropical Medicine and Hygiene, vol. 81, no. 1, pp. 13–18, 2009. View at Google Scholar · View at Scopus
  33. I. M. Hastings, “Malaria control and the evolution of drug resistance: an intriguing link,” Trends in Parasitology, vol. 19, no. 2, pp. 70–73, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. C. A. Maxwell, W. Chambo, M. Mwaimu, F. Magogo, I. A. Carneiro, and C. F. Curtis, “Variation of malaria transmission and morbidity with altitude in Tanzania and with introduction of alphacypermethrin treated nets,” Malaria Journal, vol. 2, no. 1, p. 28, 2003. View at Google Scholar · View at Scopus
  35. A. O. Talisuna, P. Langi, N. Bakyaita et al., “Intensity of malaria transmission, antimalarial-drug use and resistance in Uganda: what is the relationship between these three factors?” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 96, no. 3, pp. 310–317, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Borrmann, P. Sasi, L. Mwai et al., “Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coast,” PLoS ONE, vol. 6, no. 11, Article ID e26005, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. K. Källander, J. Nsungwa-Sabiiti, and S. Peterson, “Symptom overlap for malaria and pneumonia—policy implications for home management strategies,” Acta Tropica, vol. 90, no. 2, pp. 211–214, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. C. Mwanziva, S. Shekalaghe, A. Ndaro et al., “Overuse of artemisinin-combination therapy in Mto wa Mbu (river of mosquitoes), an area misinterpreted as high endemic for malaria,” Malaria Journal, vol. 7, no. 1, article 232, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. R. Bate, R. Tren, K. Hess, and A. Attaran, “Physical and chemical stability of expired fixed dose combination artemether-lumefantrine in uncontrolled tropical conditions,” Malaria Journal, vol. 8, no. 1, article 33, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. M. B. Denis, R. Tsuyuoka, P. Lim et al., “Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia,” Tropical Medicine & International Health, vol. 11, no. 12, pp. 1800–1807, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. D. O. Simba, D. C. Kakoko, M. Warsame et al., “Understanding caretakers' dilemma in deciding whether or not to adhere with referral advice after pre-referral treatment with rectal artesunate,” Malaria Journal, vol. 9, no. 1, article 123, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. P. N. Newton, F. M. Fernández, A. Plançon et al., “A collaborative epidemiological investigation into the criminal fake artesunate trade in South East Asia,” PLoS Medicine, vol. 5, no. 2, article e32, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus